Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Robert A. Stanger & Co. is a nationally recognized investment banking and consulting firm that specializes in the alternative investment industry. Founded in 1978, the firm provides a wide array of services including asset valuations, fairness opinions, and strategic advisory for Real Estate Investment Trusts (REITs) and Business Development Companies (BDCs). While the firm frequently advises on healthcare-related real estate assets and medical office buildings, it is a financial services entity rather than a biotechnology or life sciences company. The firm is particularly well-known for publishing "The Stanger Report," a leading source of data and analysis for the non-traded REIT and alternative investment markets. Their expertise is centered on capital markets, mergers and acquisitions, and technical consulting for complex investment structures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Robert A. Stanger & Co..